Detection and prognostic relevance of PLA2R epitopes in idiopathic membranous nephropathy: a simultaneous quantitative multiplex suspension array detection method. [PDF]
Wu J +11 more
europepmc +1 more source
Future embracing: exosomes driving a revolutionary approach to the diagnosis and treatment of idiopathic membranous nephropathy. [PDF]
Wang L +11 more
europepmc +1 more source
Randomized Prospective Controlled Open-labeled Trial of Cyclosporine with/without Low-dose Oral Corticosteroids in Idiopathic Membranous Nephropathy in Adults with Nephrotic Syndrome. [PDF]
Usui J +11 more
europepmc +1 more source
The correlation between anti-phospholipase A2 receptor antibodies and hypercoagulability in patients with idiopathic membranous nephropathy. [PDF]
Liu Y +8 more
europepmc +1 more source
A single-center retrospective study of ectopic lymphoid tissues in idiopathic membranous nephropathy: clinical pathological characteristics and prognostic value. [PDF]
Zhang J +6 more
europepmc +1 more source
Aggressive treatment may be needed for idiopathic membranous nephropathy with focal segmental glomerulosclerosis lesions. [PDF]
Cheng P +5 more
europepmc +1 more source
Traditional Chinese medicine for idiopathic membranous nephropathy: A systematic review and meta-analysis. [PDF]
Shan W +8 more
europepmc +1 more source
Idiopathic membranous nephropathy and synchronous mononeuritis multiplex secondary to idiopathic small vessel vasculitis. [PDF]
Jayanatha K +3 more
europepmc +1 more source
Related searches:
Treatment of idiopathic membranous nephropathy
Nature Reviews Nephrology, 2013Immunosuppressive treatment of patients with idiopathic membranous nephropathy (iMN) is heavily debated. The controversy is mainly related to the toxicity of the therapy and the variable natural course of the disease-spontaneous remission occurs in 40-50% of patients.
Julia M Hofstra +2 more
exaly +3 more sources
Therapy of idiopathic membranous nephropathy
Springer Seminars in Immunopathology, 1987Whether and how treating idiopathic membranous nephropathy (IMN) is still a matter of debate. While there is general agreement that nonnephrotic patients should be given symptomatic treatment alone, the results of specific therapy addressed to interfere with direct or indirect causes of renal damage are controversial.
C, Ponticelli +2 more
openaire +2 more sources

